SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis. (2012)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/emmm.201100944

PubMed Identifier: 22649008

Publication URI: http://europepmc.org/abstract/MED/22649008

Type: Journal Article/Review

Volume: 4

Parent Publication: EMBO molecular medicine

Issue: 8

ISSN: 1757-4676